Corbus Pharmaceuticals Holdings (CRBP) Non-Current Deffered Revenue (2015 - 2018)

Corbus Pharmaceuticals Holdings' Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $1.4 million for Q4 2018.

• On a quarterly basis, Non-Current Deffered Revenue rose 39.04% year-over-year to $1.4 million in Q4 2018; TTM through Dec 2018 was $1.4 million, a 39.04% increase from a year earlier, with the FY2018 full-year figure at $1.4 million, up 39.04% from the prior year.
• Non-Current Deffered Revenue improved to $1.4 million in Q4 2018 per CRBP's latest filing, from $392846.0 in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $1.4 million in Q4 2018 and bottomed at $58206.0 in Q2 2017.
• The 4-year median for Non-Current Deffered Revenue is $338470.0 (2015), against an average of $560198.6.
• Across the five-year window, Non-Current Deffered Revenue slumped 74.75% in 2016 and jumped 2224.34% in 2018, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $260260.0 in 2015, then slumped by 74.75% to $65724.0 in 2016, then soared by 1405.61% to $989550.0 in 2017, then jumped by 39.04% to $1.4 million in 2018.
• Per Business Quant, the three latest CRBP Non-Current Deffered Revenue figures stand at $1.4 million (Q4 2018), $392846.0 (Q3 2018), and $1.4 million (Q2 2018).